It’s been quite a month in the legal marijuana industry, and that’s just the beginning for one of the best marijuana stocks on the market…
Canada’s Senate passed a bill bringing the country one step closer to full legalization on June 7.
And then the FDA approved this country’s first cannabis-based drug, which treats two rare and devastating forms of epilepsy, just this week (June 25).
Renegade Investment Expert: “It’s time to double down – or even triple down – on your cannabis investments!” Read more…
Epidiolex from GW Pharmaceuticals Plc. ADR (Nasdaq: GWPH) is based on cannabidiol (CBD), one of the major compounds contained in the marijuana plant. Unlike the better-known tetrahydrocannabinol (THC), this compound does not get you high.
Both of these compounds work with receptors in the human nervous system, but CBD’s therapeutic properties are already shown to help with opioid addiction, brain cancer, ALS, and autism.
Money Morning Defense and Tech Specialist Michael A. Robinson expects Epidiolex sales alone to make $1.7 billion by 2026.
That’s just the tip of the iceberg…
You can already find CBD-based or -infused products in stores, including soothing massage cream, gummies for relaxation, hemp oil capsules, infused coffee, and vaping supplies. And because CBD also works with all mammalian systems, there are even products for pets.
Robinson expects that the overall global medical cannabis market will reach $55.8 billion by 2025.
And Robinson has uncovered a Canadian company at the center of the cannabis oil explosion.
Robinson has recommended and followed this cannabis company for two years, and it keeps getting better.
On May 24, the company uplisted, and its shares are currently trading on the New York Stock Exchange, in addition to trading on the Toronto Stock Exchange.
This move will help unlock the stock’s full potential by bringing it a wider audience, greater liquidity, and potential appreciation.
And this pot stock just raised $500 million, the largest ever for a cannabis firm…
One of the Best Ways to Play the Cannabis Boom
Canopy Growth Corp. (NYSE: CGC) is the biggest cannabis grower in Canada and is constantly expanding its capacity.
In addition to exposure in the blossoming Canadian market, Canopy already has agreements to export products to Germany, Australia, Spain, Denmark, Jamaica, Chile, and Brazil.
But over the past year, the company started to focus on cannabis oil products, which carry higher profit margins. Sales from oils increased 107% year over year, and the segment’s contribution to overall revenue rose from 14% to 18%.
Corporate investors also took note as the giant adult beverage maker Constellation Brands Inc. (NYSE: STZ) took a 9.9% stake in the company and has an option to buy more. Constellation is no stranger to this market, either, as it gained a strong presence in California ahead of that state’s vote for full legalization on Jan. 1 of this year.
Canopy’s strong performance in the stock market shouldn’t surprise anyone who is following the company either. Earlier this month, the company raised $500 million Canadian via convertible note offering, which was the largest ever in the cannabis space. The offering was upsized 25% from the previously $400 million Canadian aggregate principal amount announced just two days prior.
That gives it the capital it will need to expand – and dominate – the cannabis space.
And it won’t be just for casual smokers. CBD oils will appear in many products, and as more and more governments – from state to federal – realize that cannabis is for healing, not just recreation, this industry will reach its tipping point.
From there, the sky’s the limit, especially as cannabis legalization continues across North America…
Election Year Update: Cannabis Landslide 2018
Marijuana stocks surged up to rare 12,400% gains in the last election year.
But this veteran analyst has unveiled 16 reasons why cannabis stocks will make investors incredibly rich in the election year of 2018.
Four cannabis stocks could be destined to post the greatest profits in 2018. Learn more here in this FREE video…
About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.
Disclaimer: © 2018 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.